Jaime Rubin

1.3k total citations
36 papers, 913 citations indexed

About

Jaime Rubin is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jaime Rubin has authored 36 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 9 papers in Epidemiology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jaime Rubin's work include Cystic Fibrosis Research Advances (18 papers), Pneumonia and Respiratory Infections (5 papers) and Respiratory viral infections research (4 papers). Jaime Rubin is often cited by papers focused on Cystic Fibrosis Research Advances (18 papers), Pneumonia and Respiratory Infections (5 papers) and Respiratory viral infections research (4 papers). Jaime Rubin collaborates with scholars based in United States, United Kingdom and Italy. Jaime Rubin's co-authors include Lisa J. McGarry, Milton C. Weinstein, Michael W. Konstan, David Waltz, Keith P. Klugman, David Strutton, Gautham Marigowda, Nicole Mayer-Hamblett, Reiko Sato and Gordon MacGregor and has published in prestigious journals such as Blood, PLoS ONE and Hepatology.

In The Last Decade

Jaime Rubin

33 papers receiving 892 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaime Rubin United States 15 429 341 148 66 55 36 913
Steven Bollipo Australia 12 118 0.3× 259 0.8× 145 1.0× 26 0.4× 29 0.5× 38 698
David Nicolás Spain 17 165 0.4× 223 0.7× 137 0.9× 25 0.4× 50 0.9× 51 927
Jefferson Antonio Buendía Colombia 13 265 0.6× 196 0.6× 49 0.3× 42 0.6× 34 0.6× 103 720
Santosh Varughese India 15 87 0.2× 121 0.4× 64 0.4× 34 0.5× 49 0.9× 92 767
Dharmendra Bhadauria India 16 178 0.4× 163 0.5× 115 0.8× 11 0.2× 51 0.9× 130 874
Siu‐Ka Mak China 16 121 0.3× 112 0.3× 62 0.4× 30 0.5× 47 0.9× 39 595
Ting‐Yi Chen United States 5 82 0.2× 239 0.7× 144 1.0× 11 0.2× 75 1.4× 5 742
Hugo Farne United Kingdom 14 431 1.0× 193 0.6× 82 0.6× 4 0.1× 90 1.6× 24 983
Navjot Kaur India 13 66 0.2× 163 0.5× 146 1.0× 30 0.5× 59 1.1× 86 823
Kai Chung Tse China 14 101 0.2× 96 0.3× 77 0.5× 17 0.3× 30 0.5× 24 490

Countries citing papers authored by Jaime Rubin

Since Specialization
Citations

This map shows the geographic impact of Jaime Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaime Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaime Rubin more than expected).

Fields of papers citing papers by Jaime Rubin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaime Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaime Rubin. The network helps show where Jaime Rubin may publish in the future.

Co-authorship network of co-authors of Jaime Rubin

This figure shows the co-authorship network connecting the top 25 collaborators of Jaime Rubin. A scholar is included among the top collaborators of Jaime Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaime Rubin. Jaime Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rubin, Jaime, et al.. (2025). Impact of CFTR Modulators on Longitudinal Cystic Fibrosis Survival and Mortality: Review and Secondary Analysis. Pulmonary Therapy. 11(3). 365–386. 1 indexed citations
2.
Merlo, Christian A., Teja Thorat, Lisa J. McGarry, et al.. (2024). A Retrospective, Longitudinal Registry Study on the Long-Term Durability of Ivacaftor Treatment in People with Cystic Fibrosis. Pulmonary Therapy. 10(4). 483–494. 2 indexed citations
3.
Merlo, Christian A., Teja Thorat, Maral DerSarkissian, et al.. (2024). Long-term impact of ivacaftor on mortality rate and health outcomes in people with cystic fibrosis. Thorax. 79(10). 925–933. 8 indexed citations
4.
Merlo, Christian A., Lisa J. McGarry, Teja Thorat, et al.. (2024). Impact of age at ivacaftor initiation on pulmonary outcomes among people with cystic fibrosis. Thorax. 79(10). 915–924. 2 indexed citations
5.
Sharma, Akshay, Haydar Frangoul, Franco Locatelli, et al.. (2024). Health-Related Quality-of-Life Improvements after Exagamglogene Autotemcel in Patients with Severe Sickle Cell Disease. Blood. 144(Supplement 1). 7453–7453.
6.
Sharma, Akshay, Haydar Frangoul, Markus Y. Mapara, et al.. (2023). Improvements in Health-Related Quality of Life after Exagamglogene Autotemcel in Patients with Severe Sickle Cell Disease. Blood. 142(Supplement 1). 4999–4999. 2 indexed citations
7.
Locatelli, Franco, et al.. (2023). PB2508: COMPARING DEFINITIONS OF EPISODES OF VASO-OCCLUSION AS ENDPOINTS IN CLINICAL STUDIES OF SICKLE CELL DISEASE. HemaSphere. 7(S3). e6522522–e6522522.
8.
9.
Daly, Conor, et al.. (2023). Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del. Journal of Cystic Fibrosis. 22(4). 607–614. 69 indexed citations
10.
Thorat, Teja, Lisa J. McGarry, Machaon Bonafede, et al.. (2021). Healthcare resource utilization and costs among children with cystic fibrosis in the United States. Pediatric Pulmonology. 56(9). 2833–2844. 14 indexed citations
11.
12.
13.
14.
McColley, Susanna A., Michael W. Konstan, Bonnie W. Ramsey, et al.. (2018). Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV1. Journal of Cystic Fibrosis. 18(1). 94–101. 33 indexed citations
15.
16.
McColley, Susanna A., Michael W. Konstan, Bonnie W. Ramsey, et al.. (2015). Association between changes in percent predicted fev1 and incidence of pulmonary exacerbations, including those requiring hospitalization and/or iv antibiotics, in patients with CF treated with lumacaftor in combination with ivacaftor. Pediatric Pulmonology. 50. 282–282. 5 indexed citations
17.
18.
McGarry, Lisa J., Vivek Pawar, Jaime Rubin, et al.. (2011). Economic model of a birth cohort screening program for hepatitis C virus. Hepatology. 55(5). 1344–1355. 92 indexed citations
19.
Rubin, Jaime, Lisa J. McGarry, David Strutton, et al.. (2010). Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States. Vaccine. 28(48). 7634–7643. 86 indexed citations
20.
Winkle, Roger A., Nellis A. Smith, Michael A. Ruder, et al.. (1990). Pharmacodynamics of enoximone during intravenous infusion. International Journal of Cardiology. 28. S1–S2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven Bollipo Breakdown of academic impact, for papers by David Nicolás Breakdown of academic impact, for papers by Jefferson Antonio Buendía Breakdown of academic impact, for papers by Santosh Varughese Breakdown of academic impact, for papers by Dharmendra Bhadauria Breakdown of academic impact, for papers by Siu‐Ka Mak Breakdown of academic impact, for papers by Ting‐Yi Chen Breakdown of academic impact, for papers by Hugo Farne Breakdown of academic impact, for papers by Navjot Kaur Breakdown of academic impact, for papers by Kai Chung Tse
Rankless by CCL
2026